Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,923,078
in 11 filings, $11.2M under 10b5-1 plans

Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MIGNONE ROBERTO −$14.4M Director sold 100% of stake
  2. Francis Richard D −$10.6M President and CEO sold 21% of stake
  3. Sabag Mark −$3.9M See "Remarks" sold 53% of stake
  4. Daniell Richard −$1.9M EVP, Europe Commercial sold 45% of stake
  5. Weiss Amir −$1.1M Chief Accounting Officer sold 88% of stake
Date Insider Transaction Shares Price Value Owned after
2018-03-03 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise · Restricted Share Units −1,399 4,198
2018-03-03 McClellan Michael James EVP, Chief Financial Officer Option exercise +1,049 11,377.27
2018-03-03 McClellan Michael James EVP, Chief Financial Officer Option exercise · Restricted Share Units −1,049 3,148
2018-03-03 Griffin Deborah A Chief Accounting Officer Option exercise +1,166 1,166
2018-03-03 Griffin Deborah A Chief Accounting Officer Option exercise · Restricted Share Units −1,166 3,498
2018-03-03 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise +1,399 3,899.7
2018-03-03 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise · Restricted Share Units −1,399 4,198
2018-03-03 Daniell Richard Exec. VP, European Commercial Option exercise +2,098 2,098
2018-03-03 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −2,098 6,297
2018-03-02 Griffin Deborah A Chief Accounting Officer Grant or award · Stock Options (right to buy) +30,002 30,002
2018-03-02 Griffin Deborah A Chief Accounting Officer Grant or award · Restricted Share Units +11,764 11,764
2018-02-15 Sabag Mark EVP, Global Human Resources Sale −3,000 $20.52 $62K 41,516.54
2018-02-14 Sabag Mark EVP, Global Human Resources Sale −2,050 $18.45 $38K 44,516.54
2018-02-09 Sabag Mark EVP, Global Human Resources Grant or award · Stock Options (right to buy) +118,724 118,724
2018-02-09 Sabag Mark EVP, Global Human Resources Grant or award · Restricted Share Units +46,569 46,569
2018-02-09 Codner Iris Beck EVP Global Brand&Communication Grant or award · Stock Options (right to buy) +86,762 86,762
2018-02-09 Codner Iris Beck EVP Global Brand&Communication Grant or award · Restricted Share Units +34,031 34,031
2018-02-09 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Stock Options (right to buy) +95,890 95,890
2018-02-09 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +37,614 37,614
2018-02-09 Schultz Kare President and CEO Grant or award · Stock Options (right to buy) +205,482 205,482

Page 75 of 76 · 1,517 trades